Drug Discovery

We're speaking with biopharma expert Ivan Kairatov about a groundbreaking study that uses artificial intelligence to decode one of the immune system's fundamental secrets: how antibodies are built. For decades, a key assumption about antibody assembly has shaped therapeutic design, but a new AI

The acidic microenvironment of a solid tumor, once considered a mere byproduct of metabolism, is now being repurposed as a precise trigger for a new generation of cancer-killing vaccines designed to overcome the limitations of conventional immunotherapies. The development of pH-responsive

For decades, the story of how ADHD medications work seemed straightforward: they helped the brain focus. But recent research has completely upended that long-held belief. Today, we're speaking with Ivan Kairatov, a biopharma expert at the forefront of neuroscience and innovation. He’s here to

The intricate challenge of retraining the immune system to tolerate specific self-antigens without compromising its protective capabilities has driven the development of highly sophisticated therapeutic platforms. The emergence of engineered extracellular vesicles (EVs) represents a significant

The intricate web of biochemical signals governing the body's fat storage mechanisms has long presented a formidable challenge to medical science, but a recent discovery may have untangled a critical thread. Research has unveiled a previously unknown enzyme that acts as a master switch for fat

A ghost from medicine's past, a chemical once notorious for its lethal side effects in the pursuit of weight loss, is being cautiously resurrected by scientists aiming to solve the modern obesity crisis. This ambitious endeavor revisits a century-old idewhat if a drug could make the human body